Beijing InnoCare Raises $160 Million for Cancer/Autoimmune Drugs

Life Science

Athenex Out-Licenses China Rights to Keratosis/Oncology Drug for $29.5 Million

Life Science

TILT Holdings Agrees to Acquire Jupiter Research

Cannabis, Life Science

StemCyte Receives Phase II Investigational New Drug (IND) Clearance from the U.S. Food and Drug Administration (FDA)

Life Science

China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering

Life Science

Thousand Oaks Biopharma Closes $45 Million Series A Funding Round

Life Science

Richmond conference to predict best investments for 2019

Cannabis, Life Science

Promega Microsatellite Instability Technology Receives Innovation Designation from Chinese National Medical Products Administration

Life Science

Creso Pharma’s Plans Progress as Israel’s New Medical Cannabis Export Law Passed by Parliament

Cannabis, Life Science

APRINOIA Therapeutics Licenses Tau PET Imaging Tracer APN-1607 to Celgene

Life Science

Antengene Corporation Raises $120 Million in Series B Financing

Life Science

HJB and MabSpace Merge to Combine Bioprocessing and mAb Discovery Skills

Life Science

Cooperation best for both China and U.S., Xi tells Trump

Life Science

Luye Pharma Announces Innovative Drug – Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process

Life Science

CBD: One of the Biggest Skin Care Breakthroughs of the Year

Cannabis, Life Science